UK’s NICE Proposes Lucentis Dose-Capping Approach To Coverage For Wet AMD
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency releases new draft in response to criticism of an earlier recommendation that would limit payment to treatment in the second affected eye.